The Anatomic Pathology Track and Trace Solutions Market Size was valued at USD 642.97 million in 2022, and is expected to reach USD 1460.53 million by 2030 and grow at a CAGR of 10.8% over the forecast period 2023-2030.
Since a while ago, tracking options that make use of bar-codes have also been used in the anatomic pathology laboratories. Anatomic pathology specimens, slides tracking, and blocks all contribute to increased laboratory productivity, improved patient care, and increased patient safety. The tracking of anatomic pathology specimens also benefits research laboratories that use extra clinical data stored in biorepositories.
Get more information on Anatomic Pathology Track And Trace Solutions Market - Request Sample Report
The process of tracking implementation is difficult. Before implementing tracking, a workflow analysis in the laboratory is necessary to ensure that the system satisfies their needs. Before the launch and implementation of the tracking system, which aids in exposing the practices, analysis needs certain adjustments. The workflow must alter significantly and the laboratory culture must also adapt for tracking on the programmes. The success of the process depends on planning, buy-in, training, and accountability from each individual.
KEY DRIVERS
More Diagnostic Tests Are Being Run in Anatomic Pathology Laboratories
A Growing number of Legal Cases Concerning Cancer Misdiagnosis
Anatomic Pathology Laboratories Are Consolidating More and More
Increasing the Use of Automated Systems to Increase Laboratory Productivity
RESTRAINTS
Implementing Track and Trace Solutions in Anatomic Pathology Laboratories Comes at a High Cost
OPPORTUNITIES
Growing Quickly in APAC and Latin American Emerging Markets
Integrating Track and Trace Pathology Systems with Laboratory Information Systems
CHALLENGES
Inadequate Common Standards for Specimen Labeling in Anatomic Pathology Laboratories
Governments from all across the world are collaborating with pharmaceutical and biotech companies to address the COVID-19 epidemic, from assisting in the creation of vaccinations to preparing for problems with the supply chain for pharmaceuticals Currently, there are 117 vaccine candidates and roughly 156 chemicals in the R&D pipeline. Additionally, there has been a substantial rise in demand for common drugs like hydroxychloroquine, which is used to treat COVID-19. Due to the dearth of these treatments in many industrialized countries, there is a huge market opportunity for manufacturers of COVID-19 management therapies. The pharmaceutical and biotechnology sector is anticipated to have significant expansion in the next years because to the need for COVID-19 vaccines and treatment medications. Due to these considerations, COVID 19 is anticipated to significantly affect the market for Anatomic Pathology Track and Trace Solutions.
By Product
The market is divided into three categories: consumables, hardware, and software. The market sector predicted to hold the biggest proportion is software. This is primarily caused by the growing demand for automation of the sample labelling process to reduce manual errors, the growing emphasis on enhancing the effectiveness of anatomic laboratories, the expanding use of cloud-based LIMS, and the growing workload in anatomic pathology laboratories.
By Technology
Barcode and RFID are the segments used to group the anatomic pathology track and trace solutions market. Due in large part to end users' increased use of barcode systems as a result of their more affordable price, the barcode segment is anticipated to have a larger share of the market (as compared to RFID).
By Application
Slide tracking, tracking of tissue cassettes and blocks, and tracking of specimens are the three segments of the anatomic pathology track and trace solutions market. Slide tracking is anticipated to experience the greatest CAGR throughout the projected period, primarily as a result of the adoption of tracking systems in anatomic pathology laboratories to decrease specimen identification errors and boost workflow efficiency.
By End User
Hospital laboratories, private and reference laboratories, and other end users make track anatomic pathology and market tracking solutions (contract research organizations, government-sponsored medical laboratories, and research institutes). The section combining independent laboratories and references is expected to have the largest CAGR in the forecast period. The expansion of this market is due to the increase in the number of independent cancer screening tests and the expansion of the world's largest laboratories.
By Product
Software
Hardware
Printers and Labeling Systems
Barcode Scanners and RFID Readers
Mobile Computing Systems
Consumables
Barcode Labels and RFID Tags
Slides
Specimen Containers, Tissue Cassettes, and Blocks
Transport Bags
By Technology
Barcode
RFID
By Application
Slides Tracking
Tissue Cassettes & Blocks Tracking
Specimen Tracking
By End User
Hospital Laboratories
Independent and Reference Laboratories
.png)
Need any customization research on Anatomic Pathology Track and Trace Solutions Market - Enquiry Now
According to estimates, the North American market will rise fastest. The increased number of diagnostic tests conducted in anatomic pathology labs, the prevalence of chronic diseases (which is driving up demand for high-quality diagnostic services), and the presence of major market competitors in the area can all be attributable to this. Additionally, the demand for automated labelling systems is being driven in many anatomic pathology laboratories across North America by the need to eliminate specimen identification errors.
REGIONAL COVERAGE
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are Agilent Technologies, Cerebrum Corporation, AP Easy Software Solutions, General Data Healthcare, Leica Biosystems, Primera Technology, Thermo Fisher Scientific, Sunquest Information Systems, Ventana Medical Systems and Zebra Technologies and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 642.97 Million |
| Market Size by 2030 | US$ 1460.53 Million |
| CAGR | CAGR of 10.8% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Software, Hardware (Printers and Labeling Systems, Barcode Scanners and RFID Readers, Mobile Computing Systems), Consumables (Barcode Labels and RFID Tags, Slides, Specimen Containers, Tissue Cassettes, and Blocks, Transport Bags) • By Technology (Barcode, RFID) • By Application (Slides Tracking, Tissue Cassettes & Blocks Tracking, Specimen Tracking) • By End User (Hospital Laboratories, Independent and Reference Laboratories) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Agilent Technologies, Cerebrum Corporation, AP Easy Software Solutions, General Data Healthcare, Leica Biosystems, Primera Technology, Thermo Fisher Scientific, Sunquest Information Systems, Ventana Medical Systems and Zebra Technologies. |
| Key Drivers | • More Diagnostic Tests Are Being Run in Anatomic Pathology Laboratories • A Growing number of Legal Cases Concerning Cancer Misdiagnosis • Anatomic Pathology Laboratories Are Consolidating More and More |
| Restraints | • Implementing Track and Trace Solutions in Anatomic Pathology Laboratories Comes at a High Cost |
Ans: The expected value of the Anatomic Pathology Track and Trace Solutions Market in 2030 is USD 1460.53 million.
Ans: The CAGR of the Anatomic Pathology Track and Trace Solutions Market is 10.8% over the forecast period 2023-2030.
Growing Quickly in APAC and Latin American Emerging Markets
Integrating Track and Trace Pathology Systems with Laboratory Information Systems
More Diagnostic Tests Are Being Run in Anatomic Pathology Laboratories
A Growing number of Legal Cases Concerning Cancer Misdiagnosis
Ans: The prominent players in the market are Agilent Technologies, Cerebrum Corporation, AP Easy Software Solutions, General Data Healthcare, Leica Biosystems, Primera Technology, Thermo Fisher Scientific, Sunquest Information Systems, Ventana Medical Systems and Zebra Technologies., and others in the final report.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Anatomic Pathology Track and Trace Solutions Market Segmentation, By Product
8.1 Software
8.2 Hardware
8.2.1 Printers and Labeling Systems
8.2.2 Barcode Scanners and RFID Readers
8.2.3Mobile Computing Systems
8.3 Consumables
8.3.1 Barcode Labels and RFID Tags
8.3.2 Slides
8.5.3 Specimen Containers, Tissue Cassettes, and Blocks
8.4.4 Transport Bags
9. Anatomic Pathology Track and Trace Solutions Market Segmentation, By Technology
9.1 Barcode
9.2 RFID
10. Anatomic Pathology Track and Trace Solutions Market Segmentation, By Application
10.1 Slides Tracking
10.2 Tissue Cassettes & Blocks Tracking
10.3 Specimen Tracking
11. Anatomic Pathology Track and Trace Solutions Market Segmentation, By End User
11.1 Hospital Laboratories
11.2 Independent and Reference Laboratories
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Agilent Technologies
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Cerebrum Corporation
13.3 AP Easy Software Solutions
13.4 General Data Healthcare
13.5 Leica Biosystems
13.6 Primera Technology
13.7 Thermo Fisher Scientific
13.8 Sunquest Information Systems
13.9 Ventana Medical Systems
13.10 Zebra Technologies
14. Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Mesenchymal Stem Cells Market size was estimated USD 2.8 billion in 2022 and is expected to reach USD 7.3 billion by 2030 at a CAGR of 12.9% during the forecast period of 2023-2030.
The Blood Screening Market size was estimated USD 2.6 billion in 2022 and is expected to reach USD 4.99 billion By 2030 at a CAGR of 8.5 % during the forecast period of 2023-2030.
In 2023, The Prescription Drugs Market size amounted to USD 0.97 Billion & is estimated to reach USD 1.89 Billion by 2031 and increase at a compound annual growth rate of 8.6% between 2024 and 2031.
The Inflammatory Bowel Disease Drugs Market size was valued at USD 20.55 Billion in 2022 and is expected to reach USD 26.85 Billion By 2030 and grow at a CAGR of 3.4% over the forecast period of 2023-2030.
The Breast Imaging Market size was estimated USD 0.17 billion in 2022 and is expected to reach USD 0.28 billion by 2030 at a CAGR of 6.8% during the forecast period of 2023-2030.
The Antibiotics Market size is valued at USD 49.51 Bn in 2022 and is expected to reach USD 68.22 Bn by 2030 and grow at a CAGR of 4.09% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
